Keep pulling the thread on Dario Amodei.
US export controls on frontier chips and semiconductor manufacturing equipment to China have been a major contributor to the United States' overall lead in AI.
Frontier AI models, such as Claude Mythos Preview, pose significant cybersecurity risks with the potential to disrupt the financial sector, critical infrastructure, and national security.
The release of Claude Mythos Preview has scrambled the global cybersecurity landscape.
Anthropic has pledged to pay to absorb energy rate increases resulting from its datacenter operations.
The typical time for a drug candidate to pass through the regulatory pipeline of the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) is 7-8 years.
Anthropic’s Long-Term Benefit Trust is an independent governance body designed to hold the company to its mission.
Pending US legislation such as the MATCH and OVERWATCH acts represent a positive first step toward coordinating AI-related export controls with allies.
Anthropic is releasing a legislative proposal on frontier model testing and a policy framework for job displacement, and intends to provide substantial financial backing for these initiatives.
In 2025, Anthropic supported transparency legislation, helping to pass SB 53 in California, the RAISE Act in New York, and SB 315 in Illinois in early 2026.
Regulation for artificial intelligence should be modeled on agencies like the Federal Aviation Administration (FAA).